36 results  1 of 2 

1 Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer
Roshni D. Kalachand, Ciaran O’Riain, Sinead Toomey, Aoife Carr, Kirsten M. Timms, Sharon O’Toole, Stephen Madden, Mark Bates, John J. O’Leary, Noreen Gleeson, Dearbhaile O’Donnell, Liam Grogan, Oscar Breathnach, Angela Farrelly, Britta Stordal, Bryan T. Hennessy
Obstet Gynecol Sci.2020;63(5):643-654.   Published online 2020 September 2     DOI: http://dx.doi.org/10.5468/ogs.20033
      
2 BRCA1/BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies
Anbok Lee, Byung-In Moon, Tae Hyun Kim
Ann Lab Med.2020;40(2):114-121.   Published online 2019 October 23     DOI: http://dx.doi.org/10.3343/alm.2020.40.2.114
      
3 Clinical Validity of Next-Generation Sequencing Multi-Gene Panel Testing for Detecting Pathogenic Variants in Patients With Hereditary Breast-Ovarian Cancer Syndrome
Jaeeun Yoo, Gun Dong Lee, Jee Hae Kim, Seung Nam Lee, Hyojin Chae, Eunhee Han, Yonggoo Kim, Myungshin Kim
Ann Lab Med.2020;40(2):148-154.   Published online 2019 October 23     DOI: http://dx.doi.org/10.3343/alm.2020.40.2.148
      
4 Prevalence and oncologic outcomes of BRCA1/2 mutation and variant of unknown significance in epithelial ovarian carcinoma patients in Korea
Jun Hyeong Seo, Soo Young Jeong, Myeong Seon Kim, Jun Hyeok Kang, E Sun Paik, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun Choi
Obstet Gynecol Sci.2019;62(6):411-419.   Published online 2019 October 11     DOI: http://dx.doi.org/10.5468/ogs.2019.62.6.411
      
5 Contralateral Breast Cancer and Ipsilateral Breast Tumor Recurrence in BRCA1/2 Carriers and Non-Carriers at High-Risk of Hereditary Breast Cancer
Kyung-Hwak Yoon, Sumin Chae, Eunyoung Kang, Hee-Chul Shin, Jee Hyun Kim, In Ah Kim, So Yeon Park, Sung-Won Kim, Eun-Kyu Kim
J Breast Cancer.2019;22(4):587-598.   Published online 2019 September 30     DOI: http://dx.doi.org/10.4048/jbc.2019.22.e47
      
6 Trends in contralateral prophylactic mastectomy rate according to clinicopathologic and socioeconomic status
Ho Jong Jeon, Hyung Seok Park, Ji Soo Park, Eun Ji Nam, Seung-Tae Lee, Jeongwoo Han
Ann Surg Treat Res.2019;97(3):113-118.   Published online 2019 August 29     DOI: http://dx.doi.org/10.4174/astr.2019.97.3.113
      
7 An optimized BRCA1/2 next-generation sequencing for different clinical sample types
Yoonjung Kim, Chi-Heum Cho, Jung-Sook Ha, Do-Hoon Kim, Sun Young Kwon, Seoung Chul Oh, Kyung-A Lee
J Gynecol Oncol.2020;31(1):e9.  Published online 2019 August 6     DOI: http://dx.doi.org/10.3802/jgo.2020.31.e9
      
8 Maintenance of pegylated liposomal doxorubicin/carboplatin in patients with advanced ovarian cancer: randomized study of an Asian Gynecologic Oncology Group
Chyong-Huey Lai, Elizabeth Vallikad, Hao Lin, Lan-Yan Yang, Shih-Ming Jung, Hsueh-Erh Liu, Yu-Che Ou, Hung-Hsueh Chou, Cheng-Tao Lin, Huei-Jean Huang, Kuan-Gen Huang, Jiantai Qiu, Yao-Ching Hung, Tzu-I Wu, Wei-Yang Chang, Kien-Thiam Tan, Chiao-Yun Lin, Angel Chao, Chee-Jen Chang
J Gynecol Oncol.2020;31(1):e5.  Published online 2019 July 26     DOI: http://dx.doi.org/10.3802/jgo.2020.31.e5
      
9 Novel Germline Mutations of BRCA1 and BRCA2 in Korean Familial Breast Cancer Patients
Hee Nam Kim, Min-Ho Shin, Ran Lee, Min-Ho Park, Sun-Seog Kweon
Chonnam Med J.2019;55(2):99-103.   Published online 2019 May 23     DOI: http://dx.doi.org/10.4068/cmj.2019.55.2.99
      
10 BRCA1 and Breast Cancer: a Review of the Underlying Mechanisms Resulting in the Tissue-Specific Tumorigenesis in Mutation Carriers
Lukas Semmler, Cara Reiter-Brennan, Andreas Klein
J Breast Cancer.2019;22(1):1-14.   Published online 2019 January 22     DOI: http://dx.doi.org/10.4048/jbc.2019.22.e6
      
11 Expression of DNA Damage Response Proteins and Associations with Clinicopathologic Characteristics in Chinese Familial Breast Cancer Patients with BRCA1/2 Mutations
Xinyi Zhu, Tian Tian, Miao Ruan, Jia Rao, Wentao Yang, Xu Cai, Menghong Sun, Guangqi Qin, Zhonghua Zhao, Jiong Wu, Zhimin Shao, Ruohong Shui, Zhen Hu
J Breast Cancer.2018;21(3):297-305.   Published online 2018 September 12     DOI: http://dx.doi.org/10.4048/jbc.2018.21.e38
      
12 Status of BRCA1/2 Genetic Testing Practices in Korea (2014)
Kyungju Lee, Ja-Hyun Jang, Seung-Tae Lee, Kyong-Ah Yoon, Eun Sook Lee, Jong-Won Kim, Sun-Young Kong
Lab Med Online.2018;8(3):107-113.   Published online 2018 July 19     DOI: http://dx.doi.org/10.3343/lmo.2018.8.3.107
   
13 Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube
Min Chul Choi, Jin-Sik Bae, Sang Geun Jung, Hyun Park, Won Duk Joo, Seung Hun Song, Chan Lee, Ji-Ho Kim, Ki-Chan Lee, Sunghoon Lee, Je Ho Lee
J Gynecol Oncol.2018;29(4):e43.  Published online 2018 March 26     DOI: http://dx.doi.org/10.3802/jgo.2018.29.e43
      
14 The Effect of Reproductive Factors on Breast Cancer Presentation in Women Who Are BRCA Mutation Carrier
Ju-Yeon Kim, Hyeong-Gon Moon, Young-Joon Kang, Wonshik Han, Woo-Chul Noh, Yongsik Jung, Byung-In Moon, Eunyoung Kang, Sung-Shin Park, Min Hyuk Lee, Bo Young Park, Jong Won Lee, Dong-Young Noh
J Breast Cancer.2017;20(3):279-285.   Published online 2017 September 22     DOI: http://dx.doi.org/10.4048/jbc.2017.20.3.279
      
15 A Novel Germline Mutation in BRCA1 Causes Exon 20 Skipping in a Korean Family with a History of Breast Cancer
Kyong-Ah Yoon, Sun-Young Kong, Eun Ji Lee, Jeong Nam Cho, Suhwan Chang, Eun Sook Lee
J Breast Cancer.2017;20(3):310-313.   Published online 2017 September 22     DOI: http://dx.doi.org/10.4048/jbc.2017.20.3.310
      
16 Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates
Limor Helpman, Omri Zidan, Eitan Friedman, Sarit Kalfon, Tamar Perri, Gilad Ben-Baruch, Jacob Korach
J Gynecol Oncol.2017;28(5):e61.  Published online 2017 June 5     DOI: http://dx.doi.org/10.3802/jgo.2017.28.e61
      
17 Next-generation sequencing of BRCA1/2 in breast cancer patients: potential effects on clinical decision-making using rapid, high-accuracy genetic results
Hyung Seok Park, Seo-Jin Park, Jee Ye Kim, Sanghwa Kim, Jaegyu Ryu, Joohyuk Sohn, Seho Park, Gun Min Kim, In Sik Hwang, Jong-Rak Choi, Seung Il Kim
Ann Surg Treat Res.2017;92(5):331-339.   Published online 2017 April 27     DOI: http://dx.doi.org/10.4174/astr.2017.92.5.331
      
18 Synergistic Effect of Trabectedin and Olaparib Combination Regimen in Breast Cancer Cell Lines
Sonia Ávila-Arroyo, Gema Santamaría Nuñez, Luis Francisco García-Fernández, Carlos M. Galmarini
J Breast Cancer.2015;18(4):329-338.   Published online 2015 December 23     DOI: http://dx.doi.org/10.4048/jbc.2015.18.4.329
      
19 Early-Onset Breast Cancer in a Family with Neurofibromatosis Type 1 Associated with a Germline Mutation in BRCA1
Ye Won Jeon, Ra Mi Kim, Seung Taek Lim, Hyun Joo Choi, Young Jin Suh
J Breast Cancer.2015;18(1):97-100.   Published online 2015 March 27     DOI: http://dx.doi.org/10.4048/jbc.2015.18.1.97
      
20 Characteristics of BRCA1/2 Mutation-Positive Breast Cancers in Korea: A Comparison Study Based on Multicenter Data and the Korean Breast Cancer Registry
Jong-Han Yu, Jong Won Lee, Byung Ho Son, Sung-Won Kim, Sue K. Park, Min Hyuk Lee, Lee Su Kim, Woo-Chul Noh, Eun-Kyu Kim, Dae Sung Yoon, Jeeyeon Lee, Jin Hyang Jung, Sang Seol Jung, Gyungyup Gong, Sei-Hyun Ahn
J Breast Cancer.2014;17(2):129-135.   Published online 2014 June 27     DOI: http://dx.doi.org/10.4048/jbc.2014.17.2.129
      

 1 of 2